PRVB
Goldman Sachs’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-864,081
| Closed | -$20.8M | – | 5300 |
|
|
2023
Q1 | $20.8M | Buy |
864,081
+644,811
| +294% | +$15.5M | ﹤0.01% | 1498 |
|
|
2022
Q4 | $2.32M | Sell |
219,270
-6,053
| -3% | -$64K | ﹤0.01% | 3185 |
|
|
2022
Q3 | $1.01M | Sell |
225,323
-116,388
| -34% | -$524K | ﹤0.01% | 3812 |
|
|
2022
Q2 | $1.37M | Buy |
341,711
+98,020
| +40% | +$392K | ﹤0.01% | 3739 |
|
|
2022
Q1 | $1.78M | Sell |
243,691
-25,889
| -10% | -$189K | ﹤0.01% | 3669 |
|
|
2021
Q4 | $1.52M | Buy |
269,580
+60,343
| +29% | +$339K | ﹤0.01% | 3701 |
|
|
2021
Q3 | $1.34M | Sell |
209,237
-123,363
| -37% | -$789K | ﹤0.01% | 3781 |
|
|
2021
Q2 | $2.8M | Sell |
332,600
-7,906
| -2% | -$66.7K | ﹤0.01% | 3240 |
|
|
2021
Q1 | $3.57M | Buy |
340,506
+267,517
| +367% | +$2.81M | ﹤0.01% | 2918 |
|
|
2020
Q4 | $1.24M | Sell |
72,989
-60,928
| -45% | -$1.03M | ﹤0.01% | 3338 |
|
|
2020
Q3 | $1.72M | Buy |
133,917
+27,302
| +26% | +$350K | ﹤0.01% | 2989 |
|
|
2020
Q2 | $1.5M | Buy |
106,615
+2,375
| +2% | +$33.5K | ﹤0.01% | 2993 |
|
|
2020
Q1 | $959K | Buy |
+104,240
| New | +$959K | ﹤0.01% | 3147 |
|
|
2019
Q2 | – | Sell |
-15,727
| Closed | -$36K | – | 4322 |
|
|
2019
Q1 | $36K | Sell |
15,727
-4,008
| -20% | -$9.18K | ﹤0.01% | 4107 |
|
|
2018
Q4 | $35K | Sell |
19,735
-2,165
| -10% | -$3.84K | ﹤0.01% | 3997 |
|
|
2018
Q3 | $88K | Buy |
+21,900
| New | +$88K | ﹤0.01% | 3976 |
|